Elsevier Announces Addition to Staff at International Medicine News Group
Morristown, NJ, May 15, 2006 – Elsevier is pleased to announce the following staff addition at International Medical News Group (IMNG), publishers of leading medical newspapers. Sally Cioci has joined the sales team as National Account Manager on Skin & Allergy News.
Sally has sole advertising and project responsibilities for Skin & Allergy News and will report directly to Mark E. Altier, IMNG’s Sales Director. Sally joins IMNG from Quadrant HealthCom where she held the position of Associate Publisher/National Sales Manager for Cutis and Cosmetic Dermatology. Sally can be reached at 973-290-8200.
IMNG publishes ten medical news publications covering news and meetings worldwide for physicians: Family Practice News, Internal Medicine News, Pediatric News, Ob.Gyn. News, Skin & Allergy News, Clinical Psychiatry News, Rheumatology News, Cardiology News, Clinical Neurology News and Clinical Endocrinology News.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and 25,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).Media Contact: